CG
MRTX

Carmignac Gestion’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Carmignac Gestion’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-27,804
Closed -$1.63M – 165
2023
Q4 		$1.63M Buy
+27,804
New +$1.63M 0.03% 114